Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

Robert F. Kennedy Jr. cited a disputed study from a close network of fellow vaccine skeptics during his confirmation hearings. His critics say it is part of a pattern that raises concerns about whose ...

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

Responding to the challenges posed by the rise of new epizootics, this new technological platform will enable Ceva to develop effective, industrialized, and competitive vaccine solutions capable of ...

The World Health Organization wants to tackle inequity and bureaucracy relating to clinical trials. Will its latest guidance make a difference? Anna Volkmer reports During the covid-19 pandemic the UK ...

Readers write about Trump - a lot - along with the ongoing Summa sale and support for a statewide jobs program.

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...